Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. Our digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. Our technology is currently being used for research applications across several therapeutic areas, including neurology, oncology, cardiology, inflammation and infectious disease.
Copyright Nasdaq. Minimum 15 minutes delayed.
There are currently no events to display.